Sale of ordinary shares out of treasury

RNS Number : 2248G

The MedicX Fund Limited

02 May 2014

 



For immediate release

2 May 2014

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Sale of ordinary shares out of treasury

MedicX Fund Limited announces that earlier today, Friday 2 May 2014, it sold for cash 4,500,000 ordinary shares of no par value in the Company.  The ordinary shares were sold out of treasury by the Company, at a price per share (before expenses) of 83.50 pence.

The net proceeds will be used in further pursuing the investment objectives of the Company.

Total voting rights

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of ordinary shares in the capital of the Company in issue following this transaction will be 349,635,836 (excluding treasury shares) each with one voting right. 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules. 

The Company also holds 11,809,944 ordinary shares in treasury. 

- End -

For further information please contact:

MedicX Fund Limited                                                       [phone]

David Staples, Chairman

MedicX Group                                                                [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Canaccord Genuity Limited                                              [phone]

Andrew Zychowski / Helen Goldsmith      

Buchanan                                                                      [phone]

Charles Ryland / Sophie McNulty

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio of 133 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group.  The MedicX Group is a specialist investor, developer and manager of healthcare properties with 30 people operating across the UK. 

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

END

 

 

MSCUGURCAUPCGWP